MX2021013513A - Butirato alimenticio y sus usos. - Google Patents
Butirato alimenticio y sus usos.Info
- Publication number
- MX2021013513A MX2021013513A MX2021013513A MX2021013513A MX2021013513A MX 2021013513 A MX2021013513 A MX 2021013513A MX 2021013513 A MX2021013513 A MX 2021013513A MX 2021013513 A MX2021013513 A MX 2021013513A MX 2021013513 A MX2021013513 A MX 2021013513A
- Authority
- MX
- Mexico
- Prior art keywords
- dietary butyrate
- butyrate
- carbons
- prevention
- combinations
- Prior art date
Links
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 title abstract 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004668 long chain fatty acids Chemical class 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/003—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/10—Ester interchange
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Pediatric Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de un compuesto que tiene la fórmula (ver Fórmulas) o combinaciones de este, para proporcionar una fuente de butirato con propiedades organolépticas mejoradas en donde R1, R2, R3, R4, R5 y R6 son independientemente un ácido graso de cadena larga que tiene entre 16 y 20 carbonos la prevención y/o el tratamiento de trastornos metabólicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19175535 | 2019-05-21 | ||
PCT/EP2020/064076 WO2020234352A1 (en) | 2019-05-21 | 2020-05-20 | Dietary butyrate and its uses |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021013513A true MX2021013513A (es) | 2021-12-10 |
Family
ID=66655130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021013513A MX2021013513A (es) | 2019-05-21 | 2020-05-20 | Butirato alimenticio y sus usos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220195332A1 (es) |
EP (1) | EP3972427A1 (es) |
CN (1) | CN113840599A (es) |
AU (1) | AU2020279527A1 (es) |
BR (1) | BR112021021008A2 (es) |
MX (1) | MX2021013513A (es) |
WO (1) | WO2020234352A1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5662953A (en) * | 1989-09-20 | 1997-09-02 | Nabisco, Inc. | Reduced calorie triglyceride mixtures |
ITFI20050024A1 (it) * | 2005-02-14 | 2006-08-15 | Fernando Cantini | Lipidi per l'alimentazione degli animali |
WO2013191533A1 (en) * | 2012-06-18 | 2013-12-27 | N.V. Nutricia | Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat |
US20180332881A1 (en) * | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Preterm infant formula containing butyrate and uses thereof |
-
2020
- 2020-05-20 CN CN202080036926.XA patent/CN113840599A/zh active Pending
- 2020-05-20 EP EP20727975.3A patent/EP3972427A1/en active Pending
- 2020-05-20 MX MX2021013513A patent/MX2021013513A/es unknown
- 2020-05-20 BR BR112021021008A patent/BR112021021008A2/pt not_active IP Right Cessation
- 2020-05-20 AU AU2020279527A patent/AU2020279527A1/en active Pending
- 2020-05-20 US US17/595,451 patent/US20220195332A1/en active Pending
- 2020-05-20 WO PCT/EP2020/064076 patent/WO2020234352A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2020279527A1 (en) | 2021-10-28 |
CN113840599A (zh) | 2021-12-24 |
WO2020234352A1 (en) | 2020-11-26 |
US20220195332A1 (en) | 2022-06-23 |
EP3972427A1 (en) | 2022-03-30 |
BR112021021008A2 (pt) | 2021-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020012344A (es) | Butirato alimenticio. | |
CR20210578A (es) | Derivados de ácido itacónico y usos de estos en el tratamiento de una enfermedad inflamatoria asociada con una respuesta inmunotaria indeseable | |
MY196186A (en) | Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor | |
SA520412335B1 (ar) | مشتقات أوكسي فلورو ببريدين كمثبط كيناز | |
CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
WO2018153508A3 (en) | INHIBITORS OF SULFOXIMINE GLYCOSIDASE | |
MX2021003427A (es) | Nuevos oxadiazoles. | |
WO2021053402A3 (en) | Sulfonamide derivatives as ctps1 inhibitors | |
EP4309732A3 (en) | Modulators of pcsk9 expression | |
PH12020551995A1 (en) | Modulator of apol1 expression | |
WO2021089768A3 (en) | Treatment and prevention of a neurodegenerative disorder | |
ZA202204442B (en) | Salt forms of a complement component c5a receptor | |
MX2022006407A (es) | Composiciones bacterianas diseñadas y usos de estas. | |
WO2020102630A8 (en) | Modulators of irf5 expression | |
WO2020154499A8 (en) | Sulfonimidamide compounds and compositions for treating conditions associated with nlrp activity | |
MX2022005084A (es) | Formas sólidas de un modulador del receptor s1p a. | |
MX2022011697A (es) | Inhibidores de ciclofilina y usos de los mismos. | |
MX2021013513A (es) | Butirato alimenticio y sus usos. | |
MX2021005670A (es) | Butirato alimenticio. | |
MX2021015333A (es) | Combinaciones de inhibidores para el tratamiento de enfermedades relacionadas con la expresion de dux4. | |
MX2021005533A (es) | Trigliceridos mixtos. | |
MX2021003430A (es) | Nuevos oxadiazoles. | |
PH12019502046A1 (en) | Pyrrolotriazine derivatives as kinase inhibitor | |
MX2020013882A (es) | Derivados de tiofeno para el tratamiento de trastornos causados por ige. | |
WO2019109067A3 (en) | Creatine prodrugs, compositions and methods of use thereof |